Skip to main content

Hudson Bay Capital Management LP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1393825 STAMFORD, CT

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$193,943,261
+$173,848,961 QoQ
Shares Held
390,440
+767.6% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#75
of 1,732 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$124,182,500
PutShares
250,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. VRTX ranks #1 (34.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
390,440 $193,943,261

All Filings in VRTX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $193,943,261 390,440
2026-06-30 $124,182,500 250,000
2026-03-31 $20,094,300 45,000
2025-12-31 $74,585,880 164,518
2025-12-31 $45,336,000 100,000
2025-09-30 $17,747,166 45,315
2025-06-30 $1,291,080 2,900
2025-06-30 $3,606,120 8,100
2025-06-30 $22,369,519 50,246
2025-03-31 $24,144,036 49,800
2025-03-31 $5,526,948 11,400
2025-03-31 $24,163,913 49,841
2024-12-31 $4,033,040 10,015
2024-09-30 $13,952,400 30,000
2024-06-30 $64,449,000 137,500
2024-06-30 $64,449,000 137,500
2023-12-31 $17,089,380 42,000
2023-12-31 $15,054,930 37,000
2023-09-30 $2,434,180 7,000
2023-09-30 $2,434,180 7,000
2022-12-31 $9,240,960 32,000
2021-12-31 $7,137,000 32,500
2021-09-30 $11,336,875 62,500
2021-06-30 $11,089,650 55,000
2021-03-31 $11,346,192 52,800
2020-12-31 $7,090,200 30,000
2020-09-30 $2,721,200 10,000